South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

hetero drugs south africa (pty) ltd - tablet - see ingredients - each tablet contains tenofovir disoproxil fumarate 300,0 mg

Namibia - English - Namibia Medicines Regulatory Council

hetero labs limited - emtricitabine; tenofovir df - tablets - each tablet contains; emtricitabine 200,0 mg, tenofovir disproxil fumarate 300,0 mg

Namibia - English - Namibia Medicines Regulatory Council

hetero labs limites - abacavir - tablets - each tablet contains; abacavir sulfate equivalent to abacavir 300,0 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - gemcitabine hydrochloride, quantity: 1138 mg - injection, powder for - excipient ingredients: mannitol; sodium acetate trihydrate; sodium hydroxide - gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine is also indicated for patients with 5-fu refractory pancreatic cancer.,gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.,gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

hetero australia pty ltd - gemcitabine hydrochloride, quantity: 228 mg - injection, powder for - excipient ingredients: sodium hydroxide; mannitol; sodium acetate trihydrate - gemcitabine is indicated for treatment of patients with locally advanced or metastatic non- small cell lung cancer.,gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine is also indicated for patients with 5-fu refractory pancreatic cancer.,gemcitabine, alone or in combination with cisplatin, is indicated for treatment of patients with bladder cancer.,gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.,gemcitabine, in combination with carboplatin, is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma, who have relapsed > 6 months following platinum? based therapy

Singapore - English - HSA (Health Sciences Authority)

hetero singapore pte. ltd. - lenalidomide (form h1) - capsule - lenalidomide (form h1) 10.000 mg

Singapore - English - HSA (Health Sciences Authority)

hetero singapore pte. ltd. - lenalidomide (form h1) - capsule - lenalidomide (form h1) 15.000 mg

Singapore - English - HSA (Health Sciences Authority)

hetero singapore pte. ltd. - lenalidomide (form h1) - capsule - lenalidomide (form h1) 25.000 mg

Singapore - English - HSA (Health Sciences Authority)

hetero singapore pte. ltd. - lenalidomide (form h1) - capsule - lenalidomide (form h1) 5.000 mg

Singapore - English - HSA (Health Sciences Authority)

medicell pharmaceutical (s) pte. ltd. - linezolid - tablet, film coated - linezolid 600.00 mg